Antibacterial and Antifungal Activities of Leaf Extract of Morinda elliptica
DOI:
https://doi.org/10.33736/bjrst.4875.2022Keywords:
Antimicrobial activity, bacterial strain, fungal strains, Morinda elliptica, zone of inhibitionAbstract
This work was designed to evaluate the antimicrobial potential of Morinda elliptica by determining the zone of growth inhibition of the leaf extract against selected bacterial and fungal strains. Antifungal and antibacterial properties of the extract at different concentrations (25, 50, 100, 250 and 500 μg/ml) were investigated after successive maceration in four solvents in order of increasing polarity [hexane (180 g), dichloromethane (342 g), ethyl acetate (471 g), and methanol (384)]. The agar disc diffusion method was used against selected human bacteria Escherichia coli, Salmonella typhii, Staphylococcus aureus, and the antifungal activity of the extract against Aspergillus brasiliences and A. flavus. Zones of growth inhibition of the extract were then compared with the standard antibiotic chloramphenicol (500 μg/ml) for the antibacterial activity, and against nystatin (500 μg/ml) for antifungal activity. The result of the study showed a remarkable bactericidal activity of the plant extract against the test organisms E. coli (14.667 + 0.577) and S. typhii (13.667 + 0.577) with a weak activity against the growth of S. aureus as compared to standard (21.667 + 0.577) at 500 μg/ml. The result of the antifungal activity showed considerable activity of the plant extract against the growth of A. brasiliences (11 + 0.1000) and weak activity against the growth A. flavus at 500 μg/ml. The findings of the study indicated that the leaf extract of M. elliptica is a reservoir of bioactive compounds. The compounds can be useful in the development of new pharmaceutical products that can be effective against human pathogenic strains E. coli and S. typhii. This could serve as a lead for understanding a novel mechanism of action in future research activities.
References
Ali, A.M., Ismail, N.H., Mackeen, M.M., Yazan, L.S., Mohammed, S.M., Ho, A.S.H. & Lajis, N.H. (2000). Antiviral, cytotoxic and antimicrobial activities of anthraquinones isolated from the roots of Morinda elliptica. Pharmaceutical Biology, 38(4): 298-301.
https://doi.org/10.1076/1388-0209(200009)3841-AFT298
Apu, A.S., Muhit, M.A., Tareq, S.M., Pathan, H.A., Jamaludin, A.Y.M. & Ahmad, M. (2010). Antimicrobial activity and brine shrimp lethality bioassay of the leaves extract of Dillenia indica Linn. Journal of Young Pharmacological Research, 2(1): 50-53.
https://doi.org/10.4103/0975-1483.62213
Boyan, B., James, H. & Judicael, P. (2008). Principles of accessing bacterial susceptibility to antibiotics using agar diffusion method. Journal of Antimicrobial Chemotherapy, 61(6): 1295-1301.
https://doi.org/10.1093/jac/dkn090
Daljit, S.A. & Jasleen, K. (1999). Antimicrobial activities of spices. International Journal of Antimicrobial Agents, 12(3): 257-262.
https://doi.org/10.1016/S0924-8579(99)00074-6
Fransworth, N.R. (1993). Ethnopharmacology and future drug development: The North American experience. Journal of Ethnopharmacology, 38(2-3): 145-152.
https://doi.org/10.1016/0378-8741(93)90009-T
Gayathri, N., Gopalakrishnan, M. & Sekar, T. (2016). Phytochemical screening and antimicrobial activity of Capsicum chinense Jacq. International Journal of Advance Pharmacology, 5(1): 12-20. DOI:10.7439/ijap.v5i1.3025
Houghton, P.J. (1995). The role of plants in traditional medicine and current therapy. Journal of Alternative Complimentary Medicine, 1(2): 131-143.
https://doi.org/10.1089/acm.1995.1.131
Ismail, N.H., Alias, A. & Osman, C.P. (2000). Alkaloids and anthraquinones from Malaysian flora. In Rao, V. (Ed.) Phytochemicals- A Global Perspective of Their Role in Nutrition and Health. IntechcOpen. pp. 287-306.
Leonjang, K., Daunginda, D., Phonopaichit, S., Sawangiaroen, N., Rattanabasi, S. & Mahabusaraham, W. (2015). A new anthraquinones from Morinda elliptica. Natural Product Research, 2(l9): 1833-1838.
https://doi.org/10.1016/S0031-9422(97)00252-5
Maria, D.C.S., Helber, B.C., Patricia, M.B.F., Jose, A.V. & Debora, D.M. (2016). Antifungal activity of plant extract with potential to control plant pathogen in pineapple. Asian Pacific Journal of Tropical Biomedicine, 6(1): 26-31.
https://doi.org/10.1016/j.apjtb.2015.09.026
Morimoto, S., Nonaka, G., Chen, R. & Nishioka, I. (1998). Tannins and related compounds. LXI.: Isolation and structures of novel bi- and triflavanoids from the leaves of Cassia fistula L. Chemical and Pharmaceutical Bulletin, 36(1): 39-47.
https://doi.org/10.1248/cpb.36.39
Nayan, R.B. & Shukla, V.J. (2011). Antibacterial and antifungal activities from leaf extracts of Cassia fistula L.: An ethnomedicinal plant. Journal of Advanced Pharmaceutical Technology and Research, 2(2): 104-109.
https://doi.org/10.4103/2231-4040.82956
Prashanth, K.V., Neelam, S.C., Harish, P. & Rajani, M. (2006). Search for antibacterial and antifungal agents from selected Indian medicinal plants. Journal of Ethnopharmacology, 107(2): 182-188.
https://doi.org/10.1016/j.jep.2006.03.013
Reddy, P.S., Jamil, K. & Madhusudhan, P. (2001). Antibacterial activity of isolates from Piper longum and Taxus baccata. Pharmaceutical Biology, 39(3): 236-238.
https://doi.org/10.1076/phbi.39.3.236.5926
Runyoro, D., Matee, M., Olipa, N., Joseph, C. & Mbwambo, H. (2006). Screening of Tanzanian medicinal plants for anti-candida activity. BMC Complimentary Alternative Medicine, 6: 87-93.
https://doi.org/10.1186/1472-6882-6-11
Sandeep, S. & Abhilasha, M. (2018). Evaluation of antimicrobial and antioxidant activity of isolated constituents from areal part of Cuscuta reflexa Roxb. Asian Journal of Pharmaceutical and Clinical Research, 11(3): 191-193.
https://doi.org/10.22159/ajpcr.2018.v11i3.22475
Shahidi, B.A. (2004). Evaluation of antibacterial properties of Iranian medicinal plants against Micrococcus luteus, Serratia marcescen, Klebsiella pneumoniae and Bordetella bronchoseptica. Asian Journal of Plant Sciences, 3(1): 82-86.
https://doi.org/10.3923/ajps.2004.82.86
Sinulingga, S.E., Hasibuan, P.A. & Suryanto, D. (2018). Antibacterial activity of Karamunting (Rhodomyrtus tomentosa (Aiton) Hassk) leaf extract and fractions. Asian Journal of Pharmaceutical and Clinical Research, 11(3): 163-165.
https://doi.org/10.22159/ajpcr.2018.v11i3.23505
Srikaran, R. & Salika, S.D. (2019). Evaluation of in vitro anti-urollithiatic activity of methanolic extract of Cucumis melo seeds on calcium oxalate crystals. International Journal of Current Pharmaceutical Research, 1(1): 18-20.
https://doi.org/10.22159/ijcpr.2019v11i1.31994
Srinivasan, D., Sangeetha, N., Suresh, T. & Lakshmana, P.P. (2001). Antimicrobial activity of certain Indian medicinal plants used in folkloric medicine. Journal of Ethnopharmacology, 74(3): 217-220.
https://doi.org/10.1016/S0378-8741(00)00345-7
Vimala, S., Mohd, I.A., Abdull, R.A. & Rohana, S. (2003). Natural antioxidants: Piper sarmentosum (Kadok) and Morinda elliptica (Mengkudu). Malaysian Journal of Nutrition, 9(1): 41-51.
West, B.J., Palmer, S.K., Deng, S. & Palu, A.K. (2012). Antimicrobial activity of an iridoid rich extract from Morinda citrifolia fruit. Current Research Journal of Biological Sciences, 4(1): 52-54.
Downloads
Published
How to Cite
Issue
Section
License
Copyright Transfer Statement for Journal
1) In signing this statement, the author(s) grant UNIMAS Publisher an exclusive license to publish their original research papers. The author(s) also grant UNIMAS Publisher permission to reproduce, recreate, translate, extract or summarize, and to distribute and display in any forms, formats, and media. The author(s) can reuse their papers in their future printed work without first requiring permission from UNIMAS Publisher, provided that the author(s) acknowledge and reference publication in the Journal.
2) For open access articles, the author(s) agree that their articles published under UNIMAS Publisher are distributed under the terms of the CC-BY-NC-SA (Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License) which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original work of the author(s) is properly cited.
3) For subscription articles, the author(s) agree that UNIMAS Publisher holds copyright, or an exclusive license to publish. Readers or users may view, download, print, and copy the content, for academic purposes, subject to the following conditions of use: (a) any reuse of materials is subject to permission from UNIMAS Publisher; (b) archived materials may only be used for academic research; (c) archived materials may not be used for commercial purposes, which include but not limited to monetary compensation by means of sale, resale, license, transfer of copyright, loan, etc.; and (d) archived materials may not be re-published in any part, either in print or online.
4) The author(s) is/are responsible to ensure his or her or their submitted work is original and does not infringe any existing copyright, trademark, patent, statutory right, or propriety right of others. Corresponding author(s) has (have) obtained permission from all co-authors prior to submission to the journal. Upon submission of the manuscript, the author(s) agree that no similar work has been or will be submitted or published elsewhere in any language. If submitted manuscript includes materials from others, the authors have obtained the permission from the copyright owners.
5) In signing this statement, the author(s) declare(s) that the researches in which they have conducted are in compliance with the current laws of the respective country and UNIMAS Journal Publication Ethics Policy. Any experimentation or research involving human or the use of animal samples must obtain approval from Human or Animal Ethics Committee in their respective institutions. The author(s) agree and understand that UNIMAS Publisher is not responsible for any compensational claims or failure caused by the author(s) in fulfilling the above-mentioned requirements. The author(s) must accept the responsibility for releasing their materials upon request by Chief Editor or UNIMAS Publisher.
6) The author(s) should have participated sufficiently in the work and ensured the appropriateness of the content of the article. The author(s) should also agree that he or she has no commercial attachments (e.g. patent or license arrangement, equity interest, consultancies, etc.) that might pose any conflict of interest with the submitted manuscript. The author(s) also agree to make any relevant materials and data available upon request by the editor or UNIMAS Publisher.
